This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Mario C. Raviglione, MD; Paul P. Nunn; Arata Kochi, MD, MPH
World Health Organization Geneva, Switzerland

Dixie E. Snider, Jr, MD, MPH
Centers for Disease Control and Prevention Atlanta, Ga

JAMA. 1995;274(2):125-126.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We agree with Mr Kocs on the need to broaden our approach to tuberculosis. Kocs condemns the imbalance between disease burden and research that has been best described by the Commission on Health Research for Development: 95% of health research is done in industrialized countries, whereas 93% of the disease burden is in the developing world.¹ This must be addressed by the world health and research community.

Kocs rightly points out the need to attune tuberculosis control to local societies and cultures. Of course, far more operational research would help greatly in this regard. However, each year nearly 3 million people die of tuberculosis in the developing world. Since cost-effective techniques for treating tuberculosis in low-income countries are well established and the strategy for their implementation is known, the priority must therefore be intervention, and rapidly. The control strategy adopted by the World Health Organization has been . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?